Please login to the form below

Not currently logged in
Email:
Password:

OncoMed’s CMO steps down

Dr Jakob Dupont to leave the clinical-stage company

OncoMed Pharmaceuticals' Dr Jakob Dupont has resigned as senior vice president and chief medical officer, and is due to step down from 1 January 2017.

Dr Dupont first joined the California-based oncology specialist in 2011, having moved from Roche where he was global medical director of Avastin.

Prior to this, Dr Dupont was director of early and late stage development at Genentech, and served as a researcher in tumour immunology at the Memorial Sloan Kettering Cancer Center.

Paul Hastings, OncoMed's chairman and chief executive officer, said: “It is with great sadness that we announce Jakob's resignation.

“During his five-year tenure, Jakob has built an impressive clinical development team that is advancing seven novel anti-cancer investigational drugs in the clinic, including earlier this year, completion of enrollment in our YOSEMITE and PINNACLE randomized phase II trials.

“Although we regret Jakob's departure, we respect his decision and wish him all the best, and thank him for his many significant contributions to the company."

3rd January 2017

From: Research

Share

Tags

Subscribe to our email news alerts

PMHub

Add my company
Origins - The Patient Focused Specialists

Origins creates and delivers patient focused strategy, insights, data and solutions, which guides pharma and biotech companies to improve value...

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....